Chang Dong Liu

Chang Dong Liu

62 year
Health Technology
Consumer Services

Profile

Chang Dong Liu worked as Chief Medical Officer & Senior Vice President at Qilu Pharmaceutical Co., Ltd.
from 2015 to 2016.
He then worked as Senior Vice President-Clinical Development at Bio-Thera Solutions, Ltd.
in 2014-2015.
From 2016 to 2018, he served as Vice President-Clinical Development at Livzon MABPharm Inc. Currently, he is the Chief Scientific Officer at Ocumension Therapeutics.
Liu received his undergraduate and graduate degrees from Tongji Medical College of Huazhong University of Sci & Tech in 1983 and 1988, respectively.

Former positions of Chang Dong Liu

CompaniesPositionEnd
Corporate Officer/Principal 2018-05-31
Chief Tech/Sci/R&D Officer 2016-06-30
BIO-THERA SOLUTIONS, LTD. Corporate Officer/Principal 2015-11-30
OCUMENSION THERAPEUTICS Chief Tech/Sci/R&D Officer -
See the detail of Chang Dong Liu's experience

Training of Chang Dong Liu

Tongji Medical College of Huazhong University of Sci & Tech Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chang Dong Liu's experience

Connections

13

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BIO-THERA SOLUTIONS, LTD.

Health Technology

OCUMENSION THERAPEUTICS

Health Technology

Private companies2

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Chang Dong Liu